Navigation Links
Coventina Healthcare Enterprises, Inc. is Now ReGear Life Sciences, Inc.
Date:5/21/2008

Medical Device Maker Changes Name to Create Brand Platform, Launches New

Website, Readies for Market Entry

PITTSBURGH, May 21 /PRNewswire/ -- Coventina Healthcare Enterprises, Inc., a leader in therapeutic warming and non-pharmacologic pain management systems, announced today that it has changed its name to ReGear Life Sciences, Inc. ReGear is expanding its line of patented therapeutic warming systems which reduce pain and improve quality of life by adding a suite of products targeted at sports medicine, physical medicine and rehabilitation.

The Company, founded in 2006, offers noninvasive, non-pharmacologic pain management systems based on a patented set of radio frequency (RF) coil assemblies and generators which provide deep therapeutic heat in a safe, unattended manner and overcome the uneven and unpredictable deep-tissue warming and patient movement limitations of competing modalities such as hot packs, ultrasound, and other forms of diathermy. The company's products have been FDA cleared for unattended use and can be used to treat chronic pain, muscle spasms, joint contractures, and pain associated with osteoarthritis, soft tissue and repetitive stress injuries, slow and non-healing wounds, back injuries, fibromyalgia, carpal tunnel syndrome, and Reynaud's phenomenon.

"Our products can really make a difference in a person's life," said James (Chip) Hanlon, President and CEO. "The deep therapeutic heating we provide is known to reduce or eliminate pain, enhance recovery and rehabilitation programs, and increase one's ability to get back in the game and live a rich, active life. Changing our name to ReGear gives us a much needed platform to build our identity and brand that we believe will resonate with our target customers in sports medicine, physical medicine and rehabilitation. This sets up our planned product introduction at the National Athletic Trainer Association (NATA) trade show and is the next logical step in our launch strategy and plans to build a great company here in southwestern Pennsylvania."

About ReGear

Based in Pittsburgh, PA, ReGear Life Sciences, Inc. develops and markets innovative deep-tissue therapeutic heating products consisting of comfortable body-part specific garments powered by a portable radio frequency (RF) generator. Therapeutic levels of warming have been proven to relieve pain, decrease joint stiffness, relieve muscle spasms, increase blood flow and range of motion and facilitate a healing response. The patented system has been cleared by the FDA for unattended use. Initial investors in ReGear include Pittsburgh Life Sciences Greenhouse and Innovation Works. For additional information, visit http://www.regearlife.com.


'/>"/>
SOURCE ReGear Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. GE and Satyam Announce Global Alliance to Provide Healthcare IT Services
2. US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract
3. EDS Selects Edifecs Healthcare Accelerator Suite for Claims Processing Solution
4. RTX Healthcare Launch Wireless Telehealth Monitor With Built-in GSM/GPRS Mobile Phone Technology
5. Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
6. The German Embassy Would Like to Draw Your Attention to the Press Release of the University of Minnesota Center for German & European Studies to Present Major Healthcare Forum
7. Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008
8. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference
10. Dont Wait for the Election to Plan Your Long-Term Healthcare, Insurance Leader Advises
11. Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the upcoming 2016 Miss Arizona pageant as its official Medspa Sponsor. Dr. Josh ... Mesa, and Chandler, Arizona. , Dr. Olson says the decision to support ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: